secwatch.observer — SEC 8-K summary
======================================

Issuer:     Penumbra Inc (PEN)
CIK:        0001321732
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001321732-24-000058
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Penumbra Q1 revenue $278.7M (+15.4% YoY); U.S. thrombectomy up 35.2%; reaffirms FY24 guidance
--------------------------------------------------------------------------------

- Revenue $278.7M, up 15.4% YoY (15.2% constant currency); U.S. thrombectomy $150.3M, +35.2%.
- GAAP operating income $12.1M vs $8.0M YoY; non-GAAP operating income $19.3M.
- Adjusted EBITDA $37.6M (13.5% margin); cash & investments rose $24.3M sequentially.
- FY2024 guidance reaffirmed: total revenue growth 16-20%, U.S. thrombectomy growth 27-30%.
- Gross margin improved to 65.0% from 62.6% on favorable product mix and productivity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321732/000132173224000058/0001321732-24-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321732/000132173224000058/pen-20240507.htm
  HTML page:      https://secwatch.observer/filing/0001321732-24-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer